Skip to main content
. Author manuscript; available in PMC: 2013 Sep 19.
Published in final edited form as: Toxicol Pathol. 2013 Feb 20;41(7):1016–1027. doi: 10.1177/0192623313477754

Table 3.

Summary of cases examined by immunohistochemical staining for immune cell subsets and papillomavirus induced lesions.

Case # Description Age (years) Species Source SIV Ki-67 E6
1 SQMP and dysplasia 25.0 Mm OC +++ +
2 Polyp 14.0 Mm NEPRC +
3 Cervicitis with polyp 7.6 Mm NEPRC SHIV+ +
4 Cervicitis with dysplastic polyp 23.3 Mm NEPRC +++ +
5 Suppurative cervicitis/vaginitis with SQMP 3.9 Mm NEPRC +
6 Suppurative cervicitis/vaginitis with SQMP 15.1 Mm NEPRC +
7 Anaplastic carcinoma 12.7 Mm NEPRC SIV+ ++ +
8 Papillary carcinoma 14.9 Sgo NEPRC + +
9 WNL ND Mm OC
10 WNL 2.8 Mm NEPRC
11 WNL 19.4 Mm OC
12 WNL 6.6 Mm OC
13 Lymphoid aggregates, WNL 11.6 Mm NEPRC

Note. SQMP = squamous metaplasia; WNL = within normal limits; NEPRC = New England Primate Research Center; OC = other colony; Mm = Macaca mulatta; Sgo = Saguinus oedipus; SIV = Simian Immunodeficiency Virus; SHIV = Simian–human Immunodeficiency Virus; ND = not determined.

The amount of epithelial Ki-67 staining above the normal basal epithelial layers and the presence of papillomavirus E6 protein within the cervicovaginal epithelium is indicated.